tiprankstipranks
SCHOTT Pharma AG & Co. KGaA (STTPF)
OTHER OTC:STTPF
US Market

SCHOTT Pharma AG & Co. KGaA (STTPF) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

STTPF Analyst Ratings

Moderate Buy
7Ratings
Moderate Buy
3 Buy
4 Hold
0 Sell
Based on 7 analysts giving stock ratings to
SCHOTT
Pharma AG & Co. KGaA
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

STTPF Stock 12 Month Forecast

Average Price Target

$22.30
Based on 7 Wall Street analysts offering 12 month price targets for SCHOTT Pharma AG & Co. KGaA in the last 3 months. The average price target is $22.30 with a high forecast of $30.08 and a low forecast of $18.58. The average price target represents a change from the last price of .
eyJuYXZpZ2F0b3IiOnsiZGlzYWJsZWQiOnRydWV9LCJleHBvcnRpbmciOnsiZW5hYmxlZCI6ZmFsc2V9LCJ0aXRsZSI6eyJ0ZXh0IjpudWxsfSwiY2hhcnQiOnsiaGVpZ2h0IjoyMDAsInN0eWxlIjp7ImZvbnRGYW1pbHkiOiJSb2JvdG8gRmxleCwgLWFwcGxlLXN5c3RlbSwgQmxpbmtNYWNTeXN0ZW1Gb250LCBTZWdvZSBVSSwgUm9ib3RvLCBIZWx2ZXRpY2EsIEFyaWFsLCBzYW5zLXNlcmlmLCBBcHBsZSBDb2xvciBFbW9qaSwgU2Vnb2UgVUkgRW1vamksIFNlZ29lIFVJIFN5bWJvbCIsImZvbnRXZWlnaHQiOiI0MDAiLCJjb2xvciI6IiM1ZDVkNWUifX0sInlBeGlzIjp7ImxhYmVscyI6eyJzdHlsZSI6eyJjb2xvciI6ImluaGVyaXQifX0sInZpc2libGUiOmZhbHNlfSwicGxvdE9wdGlvbnMiOnsic2VyaWVzIjp7InN0YXRlcyI6eyJpbmFjdGl2ZSI6eyJvcGFjaXR5IjoxfX19fSwieEF4aXMiOnsibGFiZWxzIjp7InN0eWxlIjp7ImNvbG9yIjoiaW5oZXJpdCJ9fSwidmlzaWJsZSI6ZmFsc2V9LCJsZWdlbmQiOnsic3ltYm9sUmFkaXVzIjowLCJzeW1ib2xQYWRkaW5nIjo0LCJzeW1ib2xIZWlnaHQiOjE0LCJib3JkZXJXaWR0aCI6MCwic3ltYm9sV2lkdGgiOjE0LCJhbGlnbiI6ImxlZnQiLCJ2ZXJ0aWNhbEFsaWduIjoiYm90dG9tIiwiZW5hYmxlZCI6ZmFsc2V9LCJ0b29sdGlwIjp7ImJhY2tncm91bmRDb2xvciI6IndoaXRlIn0sImNyZWRpdHMiOnsiZW5hYmxlZCI6ZmFsc2V9LCJhY2Nlc3NpYmlsaXR5Ijp7ImRlc2NyaXB0aW9uIjoiIn0sInNlcmllcyI6W3sidHlwZSI6ImFyZWEiLCJkYXRhIjpbXX1dfQ==
Highest Price Target$30.08Average Price Target$22.30Lowest Price Target$18.58
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on STTPF
RBC Capital
RBC Capital
$20.9
Hold
Reiterated
06/17/26
RBC Capital Sticks to Its Hold Rating for SCHOTT Pharma AG & Co. KGaA (1SXP)
Berenberg Bank Analyst forecast on STTPF
Berenberg Bank
Berenberg Bank
$25.55
Buy
Reiterated
06/09/26
SCHOTT Pharma AG & Co. KGaA (1SXP) Gets a Buy from Berenberg Bank
Jefferies
$18$20.09
Hold
Reiterated
05/19/26
Jefferies Reaffirms Their Hold Rating on SCHOTT Pharma AG & Co. KGaA (1SXP)
DZ BANK AG Analyst forecast on STTPF
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
Buy
Reiterated
05/15/26
Deutsche Bank  Analyst forecast on STTPF
Deutsche Bank
Deutsche Bank
$18.58
Hold
Reiterated
05/14/26
Deutsche Bank Keeps Their Hold Rating on SCHOTT Pharma AG & Co. KGaA (1SXP)
UBS
$30.08
Buy
Reiterated
05/13/26
SCHOTT Pharma AG & Co. KGaA (1SXP) Receives a Buy from UBS
Barclays
$18.58
Hold
Reiterated
05/13/26
SCHOTT Pharma AG & Co. KGaA (1SXP) Gets a Hold from Barclays
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on STTPF
RBC Capital
RBC Capital
$20.9
Hold
Reiterated
06/17/26
RBC Capital Sticks to Its Hold Rating for SCHOTT Pharma AG & Co. KGaA (1SXP)
Berenberg Bank Analyst forecast on STTPF
Berenberg Bank
Berenberg Bank
$25.55
Buy
Reiterated
06/09/26
SCHOTT Pharma AG & Co. KGaA (1SXP) Gets a Buy from Berenberg Bank
Jefferies
$18$20.09
Hold
Reiterated
05/19/26
Jefferies Reaffirms Their Hold Rating on SCHOTT Pharma AG & Co. KGaA (1SXP)
DZ BANK AG Analyst forecast on STTPF
Unknown Analyst
DZ BANK AG
Not Ranked
DZ BANK AG
Buy
Reiterated
05/15/26
Deutsche Bank  Analyst forecast on STTPF
Deutsche Bank
Deutsche Bank
$18.58
Hold
Reiterated
05/14/26
Deutsche Bank Keeps Their Hold Rating on SCHOTT Pharma AG & Co. KGaA (1SXP)
UBS
$30.08
Buy
Reiterated
05/13/26
SCHOTT Pharma AG & Co. KGaA (1SXP) Receives a Buy from UBS
Barclays
$18.58
Hold
Reiterated
05/13/26
SCHOTT Pharma AG & Co. KGaA (1SXP) Gets a Hold from Barclays
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering SCHOTT Pharma AG & Co. KGaA

3 Months
Christian EhmannBerenberg Bank
Success Rate
2/6 ratings generated profit
33%
Average Return
-3.07%
Copying Christian Ehmann's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -3.07% per trade.
1 Year
Christian EhmannBerenberg Bank
Success Rate
4/6 ratings generated profit
67%
Average Return
+6.98%
Copying Christian Ehmann's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +6.98% per trade.
2 Years
Christian EhmannBerenberg Bank
Success Rate
4/6 ratings generated profit
67%
Average Return
+6.98%
Copying Christian Ehmann's trades and holding each position for 2 Years would result in 66.67% of your transactions generating a profit, with an average return of +6.98% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

STTPF Analyst Recommendation Trends

Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
3
1
1
1
1
Buy
5
2
1
2
3
Hold
15
10
9
7
7
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
13
11
10
11
In the current month, STTPF has received 4 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. STTPF average Analyst price target in the past 3 months is 22.30.
Each month's total comprises the sum of three months' worth of ratings.

STTPF Financial Forecast

STTPF Earnings Forecast

The previous quarter’s earnings for STTPF were $0.23.
The previous quarter’s earnings for STTPF were $0.23.

STTPF Sales Forecast

The previous quarter’s earnings for STTPF were $281.99M.
The previous quarter’s earnings for STTPF were $281.99M.

STTPF Stock Forecast FAQ

What is STTPF’s average 12-month price target, according to analysts?
Based on analyst ratings, SCHOTT Pharma AG & Co. KGaA’s 12-month average price target is 22.30.
    What is STTPF’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for STTPF, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is STTPF a Buy, Sell or Hold?
        SCHOTT Pharma AG & Co. KGaA has a consensus rating of Moderate Buy which is based on 3 buy ratings, 4 hold ratings and 0 sell ratings.
          What is SCHOTT Pharma AG & Co. KGaA’s price target?
          The average price target for SCHOTT Pharma AG & Co. KGaA is 22.30. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $30.08 ,the lowest forecast is $18.58. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about SCHOTT Pharma AG & Co. KGaA?
            SCHOTT Pharma AG & Co. KGaA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 7 Wall Streets Analysts.
              How can I buy shares of STTPF?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.